Richard van Steen

Founder at Life Science Pharmaceuticals, Inc.

Health Technology

Profile

Richard van Steen is associated with Life Science Pharmaceuticals, Inc. as a Director & Vice President since 2006.
He is the founder of Life Science Pharmaceuticals, Inc. which was founded in 2006.

Richard van Steen active positions

Companies	Position	Start
Life Science Pharmaceuticals, Inc. Life Science Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Life Science Pharmaceuticals, Inc. and its spin-out, Extended Delivery Pharmaceuticals (EDP), develop novel therapeutics to treat cancer, diabetes, and other serious illnesses. The private company is based in Darien, CT. Life Science Pharmaceuticals was founded in 2006 by James Fiore and Richard van Steen, and James Fiore has been the CEO since 2006. The company has a diverse portfolio of product candidates in pre-clinical and clinical development and fosters a close relationship with the academic community. LSP has licensing relationships with prestigious institutions such as the Ludwig Institute for Cancer Research (LICR), Memorial Sloan Kettering Cancer Center (MSKCC), Dana Farber Cancer Center (DFCI), and the Massachusetts Institute of Technology (MIT).	Founder	31/12/2005

All active positions of Richard van Steen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Richard van Steen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Life Science Pharmaceuticals, Inc. Life Science Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Life Science Pharmaceuticals, Inc. and its spin-out, Extended Delivery Pharmaceuticals (EDP), develop novel therapeutics to treat cancer, diabetes, and other serious illnesses. The private company is based in Darien, CT. Life Science Pharmaceuticals was founded in 2006 by James Fiore and Richard van Steen, and James Fiore has been the CEO since 2006. The company has a diverse portfolio of product candidates in pre-clinical and clinical development and fosters a close relationship with the academic community. LSP has licensing relationships with prestigious institutions such as the Ludwig Institute for Cancer Research (LICR), Memorial Sloan Kettering Cancer Center (MSKCC), Dana Farber Cancer Center (DFCI), and the Massachusetts Institute of Technology (MIT).	Health Technology